Correlation Between VIMAB Group and Cell Impact

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VIMAB Group and Cell Impact at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VIMAB Group and Cell Impact into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VIMAB Group AB and Cell Impact AB, you can compare the effects of market volatilities on VIMAB Group and Cell Impact and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VIMAB Group with a short position of Cell Impact. Check out your portfolio center. Please also check ongoing floating volatility patterns of VIMAB Group and Cell Impact.

Diversification Opportunities for VIMAB Group and Cell Impact

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between VIMAB and Cell is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding VIMAB Group AB and Cell Impact AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cell Impact AB and VIMAB Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VIMAB Group AB are associated (or correlated) with Cell Impact. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cell Impact AB has no effect on the direction of VIMAB Group i.e., VIMAB Group and Cell Impact go up and down completely randomly.

Pair Corralation between VIMAB Group and Cell Impact

Assuming the 90 days trading horizon VIMAB Group AB is expected to under-perform the Cell Impact. In addition to that, VIMAB Group is 1.56 times more volatile than Cell Impact AB. It trades about -0.37 of its total potential returns per unit of risk. Cell Impact AB is currently generating about -0.25 per unit of volatility. If you would invest  21.00  in Cell Impact AB on August 30, 2024 and sell it today you would lose (4.00) from holding Cell Impact AB or give up 19.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

VIMAB Group AB  vs.  Cell Impact AB

 Performance 
       Timeline  
VIMAB Group AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in VIMAB Group AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, VIMAB Group unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cell Impact AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

VIMAB Group and Cell Impact Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VIMAB Group and Cell Impact

The main advantage of trading using opposite VIMAB Group and Cell Impact positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VIMAB Group position performs unexpectedly, Cell Impact can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cell Impact will offset losses from the drop in Cell Impact's long position.
The idea behind VIMAB Group AB and Cell Impact AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data